PSG RxWire
Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
DRUGS APPROVED

FDA approves GSK's Flonase as an OTC treatment

FDA Approves Ryanodex for the Treatment of Malignant Hyperthermia

U.S. FDA approves Gilead blood cancer drug Zydelig

Harder-to-abuse oxycodone painkiller approved


PBMI E-Learning
SUMMARY OF TOP ARTICLES - JULY 31, 2014

FedEx charges raise online pharmacy issues
Associated Press - July 26, 2014
FedEx, the latest company accused in a federal probe involving illegal online pharmacies, says it will fight the charges that it knowingly shipped drugs to people who lack valid prescriptions.

Medical, Pharma Groups Ask CMS for Details on Payment Database
iHealthBeat - July 29, 2014
On Monday, several medical societies and a pharmaceutical industry group sent a letter to CMS asking for more details about how data will be displayed on its soon-to-be released physician payment database, Wall Street Journal's "Pharmalot" reports

Report: Medicare Solvency Extended by Four Years, Bolstered by ACA
California Healthline - July 29, 2014
Medicare's trust fund will remain solvent until 2030 -- four years longer than predicted last year -- according to a report released Monday by Medicare's trustees, the Washington Post reports.

Surgeon General issues call to action to prevent skin cancer
U.S. Department of Health & Human Services - July 29, 2014
Skin cancer, the most commonly diagnosed cancer in the United States, is a major public health problem that requires immediate action, according to a new Call to Action released today by the U.S. Surgeon General.

HIV Pills Show More Promise to Prevent Infection
Associated Press - July 22, 2014
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.

Abuse of U.S. generic-drug rules costs billions: report
Reuters - July 23, 2014
U.S. rules that ensure prescription medicines are not misused have been manipulated by brand-name drug companies to fight off generic competitors, costing consumers billions of dollars, according to a report released on Wednesday.

Safety profile of blockbuster blood thinner comes under question
Los Angeles Times - July 23, 2014
A new investigation has raised fresh questions about a bestselling prescription medication to reduce stroke risk in those with the heart rhythm disorder known as atrial fibrillation.

MedImmune Fights Pediatricians' New Advice
Associated Press - July 28, 2014
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.

Flint company Diplomat plans $100 million IPO, would become shareholder-owned
MLive-The Flint Journal - July 24, 2014
Flint-based specialty pharmacy Diplomat has filed paperwork with the U.S. Securities and Exchange Commission for an initial public offering of stocks, hoping to raise $100 million.

When Hospitals Buy Clinics, Prices Go Up
Bloomberg - July 24, 2014
For the past four years, Pennsylvania insurance company Highmark has watched its bills for cancer care skyrocket. The increase wasn’t because of new drugs being prescribed or a spike in diagnoses. Instead, the culprit was a change that had nothing to do with care: Previously independent oncology clinics and private practices have been acquired by big hospital systems that charge higher rates, sometimes three times as much, for chemotherapy drugs.


Contact,

Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com

PSGNewsletter@PSGConsults.com
www.PSGConsults.com